Human IgA- and IgM-globulins for clinical use.
D000361:Agammaglobulinemia / Q000517:prevention & control; D000906:Antibodies / Q000032:analysis; D004927:Escherichia coli Infections / Q000517:prevention & control; D006801:Humans; D007106:Immune Sera / Q000032:analysis; D005779:Immunodiffusion; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000627:therapeutic use*; D007075:Immunoglobulin M / Q000008:administration & dosage / Q000627:therapeutic use*; D007136:Immunoglobulins / Q000627:therapeutic use; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control; D007235:Infant, Premature, Diseases / Q000517:prevention & control; D007273:Injections, Intramuscular; D011552:Pseudomonas Infections / Q000517:prevention & control; D012480:Salmonella Infections / Q000517:prevention & control; D013301:Streptolysins / Q000032:analysis; D013743:Tetanus Antitoxin / Q000032:analysis; D014461:Ultracentrifugation; D014945:Wound Healing
D000906:Antibodies; D007106:Immune Sera; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D013301:Streptolysins; D013743:Tetanus Antitoxin